Perbak Capital Partners’s Eastman Chemical EMN Stock Holding History

Perbak Capital Partners’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,338	Closed	-$468K	–	328
2025 Q4	$468K	Sell	7,338 -14,840	-67%	-$915K	0.14%	42
2025 Q3	$1.4M	Buy	22,178 +11,047	+99%	+$771K	0.25%	38
2025 Q2	$831K	Buy	11,131 +7,306	+191%	+$574K	0.19%	88
2025 Q1	$337K	Buy	+3,825	New	+$361K	0.25%	91

Other funds holding EMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Perbak Capital Partners's EMN Position: Q1 2026 in Review

Perbak Capital Partners sold out of Eastman Chemical (EMN) in Q1 2026, closing a stake of 7,338 shares — an estimated $468K sold.

Perbak Capital Partners first reported a position in EMN in Q1 2025 and held it in 4 quarters. The position peaked at $1.4M in Q3 2025. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

Perbak Capital Partners reported no remaining Eastman Chemical position as of Q1 2026 after selling out during the quarter.
Perbak Capital Partners sold 7,338 Eastman Chemical shares in Q1 2026, an estimated $468K.
Perbak Capital Partners first reported a position in Eastman Chemical in Q1 2025 and held it in 4 quarters.
Perbak Capital Partners's Eastman Chemical position peaked at $1.4M in Q3 2025.
634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Perbak Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.